Form 8-K - Current report:
SEC Accession No. 0000950170-22-004080
Filing Date
2022-03-17
Accepted
2022-03-17 16:06:02
Documents
14
Period of Report
2022-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K biol-20220317.htm   iXBRL 8-K 58715
2 EX-99.1 biol-ex99_1.htm EX-99.1 741022
3 GRAPHIC img239377025_0.jpg GRAPHIC 7439
  Complete submission text file 0000950170-22-004080.txt   966656

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biol-20220317.xsd EX-101.SCH 2497
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biol-20220317_pre.xml EX-101.PRE 11669
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biol-20220317_lab.xml EX-101.LAB 19238
8 EXTRACTED XBRL INSTANCE DOCUMENT biol-20220317_htm.xml XML 4935
Mailing Address 27042 TOWNE CENTRE DRIVE SUITE 270 FOOTHILL RANCH CA 92610
Business Address 27042 TOWNE CENTRE DRIVE SUITE 270 FOOTHILL RANCH CA 92610 949-361-1200
BIOLASE, INC (Filer) CIK: 0000811240 (see all company filings)

EIN.: 870442441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36385 | Film No.: 22748499
SIC: 3843 Dental Equipment & Supplies